Clinical Trial

Korean Heart Failure Registry III

Study acronym: KorHF-III
Recruiting
View on ClinicalTrials.gov →
Summary
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.
Trial Details
NCT Number NCT04329234
Lead Sponsor Seoul National University Bundang Hospital
Collaborators: Korean Society of Heart Failure
Conditions Acute Heart Failure
Enrollment 10,000 participants
Start Date 2018-10-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2020-04-01